IJMDC. 2020; 4(9): 1491-1494

The efficacy and safety of Rifaximin in the management of hepatic encephalopathy

Authors: Mohannad Ali Alghamdi, Hassan Abdulrahman Eissa.

ABSTRACT

Hepatic encephalopathy (HE) is a clinical condition that results in the decline of brain function as a result of severe liver disease. Rifaximin is an antibiotic of non-absorbable nature that is derived from rifamycin used for the HE treatment. The aim of this review was to determine the efficacy, safety, and outcomes of rifaximin in the treatment of HE. A systematic search was performed using PubMed database for clinical trials involving rifaximin and treatment of hepatic encephalopathy. Specific keywords were employed to obtain all possible results during the systematic research. The option to include clinical trials was selected in the database home screen to limit the search to clinical trials. The present study reviewed and analyzed five clinical trials that were published between the year 2010 and 2016. The selected studies were summarized based on the abstract of the study; author and publication year, study design, sample size, type of diagnosis, treatment regimen, and major findings. The current study found that rifaximin can be used for the treatment of minimal HE and HE. One dose of rifaximin is preferred for the treatment of HE, whereas in overt HE the combination therapy is the choice of the preference.

Keywords:
HE treatment, rifaximin, clinical trials, rifaximin efficacy


View PDF
The efficacy and safety of Rifaximin in the management of hepatic encephalopathy


Authors
Mohannad Ali Alghamdi
Resident, Department of Gynecology and Obstetrics, King Fahad hospital, Riyadh, Saudi Arabia
PubMed articlesGoogle scholar articles

Hassan Abdulrahman Eissa
General practitioner, Security Forces Hospital, Riyadh, Saudi Arabia
PubMed articlesGoogle scholar articles


Correspondence to:
. Mohannad Ali Alghamdi, Security Forces Hospital, Riyadh, Saudi Arabia.; dr.md.med@hotmail.com

Publication history
Published online 01 Jan 1970
Received 27 Jan 2019
Accepted 04 Feb 2019
Published in print 08 Sep 2020

How to cite this article?

Export to EndNote Export to refMan

Pubmed Style

Alghamdi MA, Eissa HA. The efficacy and safety of Rifaximin in the management of hepatic encephalopathy. IJMDC. 2020; 4(9): 1491-1494. doi:10.24911/IJMDC.51-1548629244


Web Style

Alghamdi MA, Eissa HA. The efficacy and safety of Rifaximin in the management of hepatic encephalopathy. http://www.ijmdc.com/?mno=28203 [Access: October 25, 2020]. doi:10.24911/IJMDC.51-1548629244


AMA (American Medical Association) Style

Alghamdi MA, Eissa HA. The efficacy and safety of Rifaximin in the management of hepatic encephalopathy. IJMDC. 2020; 4(9): 1491-1494. doi:10.24911/IJMDC.51-1548629244


Vancouver/ICMJE Style

Alghamdi MA, Eissa HA. The efficacy and safety of Rifaximin in the management of hepatic encephalopathy. IJMDC. (2020), [cited October 25, 2020]; 4(9): 1491-1494. doi:10.24911/IJMDC.51-1548629244


Harvard Style

Alghamdi, M. A. & Eissa, . H. A. (2020) The efficacy and safety of Rifaximin in the management of hepatic encephalopathy. IJMDC, 4 (9), 1491-1494. doi:10.24911/IJMDC.51-1548629244


Turabian Style

Alghamdi, Mohannad Ali, and Hassan Abdulrahman Eissa. 2020. The efficacy and safety of Rifaximin in the management of hepatic encephalopathy. International Journal of Medicine in Developing Countries, 4 (9), 1491-1494. doi:10.24911/IJMDC.51-1548629244


Chicago Style

Alghamdi, Mohannad Ali, and Hassan Abdulrahman Eissa. "The efficacy and safety of Rifaximin in the management of hepatic encephalopathy." International Journal of Medicine in Developing Countries 4 (2020), 1491-1494. doi:10.24911/IJMDC.51-1548629244


MLA (The Modern Language Association) Style

Alghamdi, Mohannad Ali, and Hassan Abdulrahman Eissa. "The efficacy and safety of Rifaximin in the management of hepatic encephalopathy." International Journal of Medicine in Developing Countries 4.9 (2020), 1491-1494. Print. doi:10.24911/IJMDC.51-1548629244


APA (American Psychological Association) Style

Alghamdi, M. A. & Eissa, . H. A. (2020) The efficacy and safety of Rifaximin in the management of hepatic encephalopathy. International Journal of Medicine in Developing Countries, 4 (9), 1491-1494. doi:10.24911/IJMDC.51-1548629244


Share this article

Click the icon of the social media platform on which you would like to share this article.

Article Statistics

Request permissions

If you wish to reuse any part or all of this article please contact the copyright holder, contact@ijmdc.com.

Copyright ©2020 Discover STM Publishing. All Rights Reserved.